These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16737471)

  • 1. Prevention of intraventricular haemorrhage: a role for recombinant activated factor VII?
    Robertson JD
    J Paediatr Child Health; 2006 Jun; 42(6):325-31. PubMed ID: 16737471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraventricular hemorrhage in preterm infants: coagulation perspectives.
    Kuperman AA; Kenet G; Papadakis E; Brenner B
    Semin Thromb Hemost; 2011 Oct; 37(7):730-6. PubMed ID: 22187395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraventricular hemorrhage in preterm infants and coagulation--ambivalent perspectives?
    Kuperman AA; Brenner B; Kenet G
    Thromb Res; 2013 Jan; 131 Suppl 1():S35-8. PubMed ID: 23452738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic effect of recombinant factor VIIa in factor VII deficient patients.
    Mathijssen NC; Masereeuw R; Verbeek K; Lavergne JM; Costa JM; van Heerde WL; Nováková IR
    Br J Haematol; 2004 May; 125(4):494-9. PubMed ID: 15142120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery.
    Manning BJ; Hynes N; Courtney DF; Sultan S
    Eur J Vasc Endovasc Surg; 2005 Nov; 30(5):525-7. PubMed ID: 16099693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic treatment of a small child with severe factor VII deficiency using repeat dosing from a single vial of recombinant activated factor VII.
    Michaels LA; Philipp CS; Eisele J; Pappas H; Saidi P
    Pediatr Blood Cancer; 2007 Oct; 49(5):736-9. PubMed ID: 16317734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraventricular haemorrhage in preterm infants--can we improve outcome by addressing coagulation?
    Kuperman AA; Brenner B; Kenet G
    J Matern Fetal Neonatal Med; 2015 Nov; 28 Suppl 1():2265-7. PubMed ID: 23968273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of recombinant factor VIIa in a preterm infant with coagulopathy and subdural hematoma.
    Altuncu E; Berrak S; Bilgen H; Yurdakul Z; Canpolat C; Ozek E
    J Matern Fetal Neonatal Med; 2007 Aug; 20(8):627-9. PubMed ID: 17674281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnosis, management, and postnatal prevention of intraventricular hemorrhage in the preterm neonate.
    McCrea HJ; Ment LR
    Clin Perinatol; 2008 Dec; 35(4):777-92, vii. PubMed ID: 19026340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of recombinant factor VIIa in infants with severe coagulopathy.
    Fontaine MJ; Lazarchick J; Taylor S; Annibale D
    J Perinatol; 2004 May; 24(5):310-1. PubMed ID: 15116125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet function in term and preterm neonates.
    Saxonhouse MA; Sola MC
    Clin Perinatol; 2004 Mar; 31(1):15-28. PubMed ID: 15183653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Administration of activated recombinant factor VII (novo seven) for the control of massive bleeding in gynecology].
    Tanchev S; Pandurski F; Georgiev A; Gesheva Iu; Platikanov V; Dinov P
    Akush Ginekol (Sofiia); 2004; 43 Suppl 2():32-5. PubMed ID: 15518274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Life-threatening hemorrhage in neonates: management with recombinant activated factor VII.
    Veldman A; Fischer D; Voigt B; Beyer PA; Schlösser R; Allendorf A; Kreuz W
    Intensive Care Med; 2002 Nov; 28(11):1635-7. PubMed ID: 12415453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant activated factor VII and the anaesthetist.
    Welsby IJ; Monroe DM; Lawson JH; Hoffmann M
    Anaesthesia; 2005 Dec; 60(12):1203-12. PubMed ID: 16288618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refractory bleeding following major surgery of a giant sacrococcygeal teratoma in a premature infant: successful use of recombinant factor VIIa.
    Girisch M; Rauch R; Carbon R; Habash T; Hofbeck M
    Eur J Pediatr; 2004 Feb; 163(2):118-9. PubMed ID: 14716558
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of recombinant activated factor VII in massive obstetric haemorrhage.
    Haynes J; Laffan M; Plaat F
    Int J Obstet Anesth; 2007 Jan; 16(1):40-9. PubMed ID: 17126006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of recombinant factor VIIa for bleeding in paediatric practice.
    Millar CG; Stringer MD; Sugarman I; Richards M
    Haemophilia; 2005 Mar; 11(2):171-4. PubMed ID: 15810920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective pilot study of prophylactic treatment of preterm neonates with recombinant activated factor VII during the first 72 hours of life.
    Veldman A; Josef J; Fischer D; Volk WR
    Pediatr Crit Care Med; 2006 Jan; 7(1):34-9. PubMed ID: 16395072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does risk-based coagulation screening predict intraventricular haemorrhage in extreme premature infants?
    Tran TT; Veldman A; Malhotra A
    Blood Coagul Fibrinolysis; 2012 Sep; 23(6):532-6. PubMed ID: 22627584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Off-license" use of recombinant activated factor VII.
    Ghorashian S; Hunt BJ
    Blood Rev; 2004 Dec; 18(4):245-59. PubMed ID: 15501553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.